Identification and inhibition of the Cyclin D Rb-docking interface that drives cell division
The animal cell division cycle is initiated by the cyclin-dependent kinases CDK4 and CDK6 in complex with D-type cyclins. Cyclin D-CDK4/6 complex formation is promoted by the assembly factors p21 and p27, which bind both subunits. p27 binds the hydrophobic patch on cyclin D that is similar to the patch used by other cell cycle cyclins to dock their substrates. This raised the question as to how cyclin D could find its substrates if its hydrophobic patch were already occupied? Here, we show that D-type cyclins use their A2' helix to dock the retinoblastoma protein Rb, a key substrate regulating cell cycle progression. The specific interface of cyclin D's A2' helix is unique among cyclins and its mutation slows proliferation. Taken together, our work identifies a cyclin D-substrate docking mechanism that can be targeted by novel cancer therapeutics.
Authors
- Ioannis Sanidas (ORCID: https://orcid.org/0000-0002-9063-6840)
- Mardo Kõivomägi (ORCID: https://orcid.org/0000-0003-4691-6930)
- Jan Marcel Skotheim (ORCID: https://orcid.org/0000-0001-8420-6820)
- Michael C. Lanz (ORCID: https://orcid.org/0000-0001-8175-7627)
- Jürgen Tuvikene
- Shuyuan Zhang (ORCID: https://orcid.org/0000-0002-6220-5998)
- Julien Sage
- Cecelia Fleming
- Shicong Xie
- Aiden Weaver
- Benjamin Reyes Topacio
- Seth Rubin
Institutions
- National Institutes of Health (US)
- University of California, Santa Cruz (US)
- Massachusetts General Hospital (US)
- Chan Zuckerberg Initiative (United States) (US)
- National Cancer Institute (US)
- Pediatrics and Genetics (US)
- Center for Cancer Research (US)
- Stanford University (US)
Publication Details
- Journal
- bioRxiv (Cold Spring Harbor Laboratory)
- Published
- 2026-01-15
- DOI
- https://doi.org/10.64898/2026.01.14.699544
- Primary Topic
- Cancer-related Molecular Pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.00